Prof Linda Mileshkin
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
552 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
Exploring patterns of acute and primary care utilisation before diagnosis, during treatment and for 3 years postcompletion of surgery and adjuvant treatment in women with endometrial cancer: a protocol for a Victorian data linkage study.
DOI: 10.1136/bmjopen-2026-1263052026
Journal article
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
DOI: 10.1200/JCO-25-029742020
Research Grant
Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
2020
Research grants (ARC, NHMRC, MRFF)
Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
2020
Research Grant
ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature144102013
Journal article
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
DOI: 10.1002/path.4251
RECENT SCHOLARLY WORKS
2026
Journal article
Erratum: Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
DOI: 10.1200/JCO-26-022852026
Journal article
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial
DOI: 10.1038/s41416-026-03535-62026
Journal article
FINAL OVERALL SURVIVAL RESULTS FROM THE PHASE 3 ROSELLA TRIAL: RELACORILANT PLUS NAB-PACLITAXEL VS NAB-PACLITAXEL MONOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER
DOI: 10.1016/j.ijgc.2026.1050492026
Journal article
IMPACT OF STAGING, OVERALL TREATMENT TIME AND BRACHYTHERAPY PRESCRIPTION ON OUTCOMES IN THE OUTBACK INTERNATIONAL RANDOMISED TRIAL(ANZGOG 0902/RTOG 1174/NRG 0274)
DOI: 10.1016/j.ijgc.2026.1051382026
Journal article
Quality Assurance Analysis of Staging and Radiotherapy in OUTBACK Trial: Impact of Protocol Permitted Variations on Clinical Outcomes in Locally Advanced Cervical Cancer
DOI: 10.1016/j.ijrobp.2026.06.23882026
Journal article
Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting
DOI: 10.1016/j.ijgc.2026.1048272026
Journal article
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma
DOI: 10.1016/j.ejca.2026.1168852026
Journal article
Assessing Foundation Models for Computational Pathology in Endometrial Cancer.
DOI: 10.1016/j.modpat.2026.101070